Morgan Partners Global Investors Selldown L P JP II's Net Worth
$1.75 Billion
Who is Morgan Partners Global Investors Selldown L P JP II?
Morgan Partners Global Investors Selldown L P JP II has an estimated net worth of $1.75 Billion. This is based on reported shares across multiple companies, which include PHARMOS CORP, Aramark, Emergent BioSolutions Inc., Kraton Performance Polymers, Inc., and SEATTLE GENETICS INC /WA.
SEC CIK
Morgan Partners Global Investors Selldown L P JP II's CIK is 0001361608
Past Insider Trading and Trends
2007 was Morgan Partners Global Investors Selldown L P JP II's most active year for acquiring shares with 8 total transactions. Morgan Partners Global Investors Selldown L P JP II's most active month to acquire stocks was the month of January. 2008 was Morgan Partners Global Investors Selldown L P JP II's most active year for disposing of shares, totalling 32 transactions. Morgan Partners Global Investors Selldown L P JP II's most active month to dispose stocks was the month of April. 2007 saw Morgan Partners Global Investors Selldown L P JP II paying a total of $0.00 for 2,045,000 shares, this is the most they've acquired in one year. In 2015 Morgan Partners Global Investors Selldown L P JP II cashed out on 26,532,756 shares for a total of $824,329,338.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PHARMOS CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aramark (ARMK) Snapshot price: $29.015
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.23M |
$30.98 | -$192,872,805.60 |
0
|
Jul 1
| |||
Form 4
| -54.64% | -7.50M |
$31.47 | -$236,025,000.00 | 6.23M |
May 27
| |||
Form 4
| -28.96% | -5.60M |
$32.16 | -$179,945,040.96 | 13.73M |
Mar 26
| |||
Form 4
| -27.18% | -7.21M |
$29.88 | -$215,486,492.40 | 19.32M |
Feb 23
| |||
Form 4
| -23.81% | -8.29M |
$27.02 | -$224,090,153.84 | 26.53M |
Dec 17
| |||
Form 4
| -12.64% | -5.04M |
$24.54 | -$123,686,614.78 | 34.83M |
Jun 4
| |||
Form 4
| -5.98% | -2.53M |
$18.90 | -$47,898,799.20 | 39.87M |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Emergent BioSolutions Inc. (EBS) Snapshot price: $1.515
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Kraton Performance Polymers, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SEATTLE GENETICS INC /WA (SGEN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.20% | -21.50K |
$10.36 | -$222,740.00 | 1.77M |
Jul 25 - Jul 28
| |||
Form 4
| -7.94% | -150.00K |
$10.81 | -$1,621,500.00 | 1.74M |
Jul 25
| |||
Form 4
| -5.57% | -122.89K |
$10.10 | -$1,241,219.30 | 2.08M |
May 14
| |||
Form 4
| -2.28% | -51.54K |
$10.06 | -$518,452.16 | 2.2M |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +0.05% | 270 |
$8.57 | -$17,266,236.10 | 522.22K |
Feb 9
| |||
No matching records found |